Role of nitric oxide and guanosine 3',5'-cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea-pig pulmonary arteries
- PMID: 1335345
- PMCID: PMC1907763
- DOI: 10.1111/j.1476-5381.1992.tb14538.x
Role of nitric oxide and guanosine 3',5'-cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea-pig pulmonary arteries
Abstract
1. Nonadrenergic, noncholinergic (NANC) nerves mediate vasodilatation in guinea-pig pulmonary artery (PA) by both endothelium-dependent and endothelium-independent mechanisms. The transmitter(s) involved in the endothelium-independent pathway have not yet been identified. We have therefore investigated the possibility that nitric oxide (NO) and guanosine 3',5'-cyclic monophosphate (cyclic GMP) may mediate this neural vasodilator response in guinea-pig branch PA rings denuded of endothelium. 2. Electric field stimulation (EFS, 50 V, 0.2 ms) induced a frequency-dependent (1-24 Hz), tetrodotoxin-sensitive relaxation of the U44069-precontracted PA rings in the presence of adrenergic and cholinergic blockade. 3. The NO synthase inhibitors NG-monomethyl L-arginine (L-NMMA, 100 microM) and NG-nitro L-arginine methyl ester (L-NAME, 30 microM), and the guanylyl cyclase inhibitor methylene blue (5 microM) inhibited the EFS (16 Hz)-induced relaxation by 53 +/- 5, 74 +/- 9 and 82 +/- 9% respectively (n = 5-7, P < 0.01, compared with control rings). 4. Excess concentrations of L-, but not D-arginine (300 microM) completely reversed the inhibitory effect of L-NMMA. 5. The EFS-elicited relaxation (4 Hz) was potentiated by 1 microM zaprinast, a type V phosphodiesterase inhibitor which inhibits guanosine 3':5'-cyclic monophosphate (cyclic GMP) degradation, but was unaffected by 0.1 microM zardaverine, a type III/IV phosphodiesterase inhibitor which inhibits cyclic AMP degradation. 6. EFS (50 V, 0.2 ms, 16 Hz) induced a 3 fold increase in tissue cyclic GMP content, an action which was inhibited by L-NMMA (100 microM). 7. Pyrogallol (100microM), a superoxide anion generator, also inhibited the EFS-induced relaxation by 53 +/- 9%, and this effect was prevented by superoxide dismutase.8. Chemical sympathetic denervation with 6-hydroxydopamine had no effect on the relaxant response to EFS in the endothelium-denuded PA rings.9. In endothelium-denuded branch PA rings at resting tone, L-NMMA (100 microM) significantly augmented the adrenergic contractile response, an effect which was completely reversed by L-arginine,but not by D-arginine. In the same groups of vessel rings, L-NMMA had no significant effect on the matched contractile response to exogenous noradrenaline.10. These results suggest that NO may be released from intramural nerve endings other than adrenergic nerves (probably NANC nerves), and this leads to vasodilatation via activation of guanylyl cyclase.
Similar articles
-
The effects of selective phosphodiesterase III and V inhibitors on adrenergic and non-adrenergic, non-cholinergic relaxation responses of guinea-pig pulmonary arteries.Auton Autacoid Pharmacol. 2003 Apr;23(2):117-24. doi: 10.1046/j.1474-8673.2003.00284.x. Auton Autacoid Pharmacol. 2003. PMID: 14511071
-
Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.Br J Pharmacol. 1991 Oct;104(2):495-503. doi: 10.1111/j.1476-5381.1991.tb12457.x. Br J Pharmacol. 1991. PMID: 1665741 Free PMC article.
-
Endothelium-dependent nonadrenergic, noncholinergic neural relaxation in guinea pig pulmonary artery.J Pharmacol Exp Ther. 1992 Feb;260(2):541-8. J Pharmacol Exp Ther. 1992. PMID: 1738104
-
The role of nitric oxide in erectile dysfunction: implications for medical therapy.J Clin Hypertens (Greenwich). 2006 Dec;8(12 Suppl 4):53-62. doi: 10.1111/j.1524-6175.2006.06026.x. J Clin Hypertens (Greenwich). 2006. PMID: 17170606 Free PMC article. Review.
-
Evidence for the existence of a constitutive nitric oxide synthase in vascular smooth muscle.Clin Exp Pharmacol Physiol. 2002 Aug;29(8):725-7. doi: 10.1046/j.1440-1681.2002.03707.x. Clin Exp Pharmacol Physiol. 2002. PMID: 12100009 Review.
Cited by
-
Nitric oxide and lung disease.Thorax. 1993 Oct;48(10):1034-43. doi: 10.1136/thx.48.10.1034. Thorax. 1993. PMID: 7903007 Free PMC article. Review. No abstract available.
-
Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.Br J Pharmacol. 1999 Nov;128(5):1082-8. doi: 10.1038/sj.bjp.0702874. Br J Pharmacol. 1999. PMID: 10556946 Free PMC article.
-
An investigation of the effects of zaprinast, a PDE inhibitor, on the nitrergic control of the urethra in anaesthetized female rats.Br J Pharmacol. 2002 Jun;136(3):399-414. doi: 10.1038/sj.bjp.0704735. Br J Pharmacol. 2002. PMID: 12023943 Free PMC article.
-
Nitric oxide donors enhanced Ca2+ currents and blocked noradrenaline-induced Ca2+ current inhibition in rat sympathetic neurons.J Physiol. 1995 Feb 1;482 ( Pt 3)(Pt 3):521-31. doi: 10.1113/jphysiol.1995.sp020537. J Physiol. 1995. PMID: 7738846 Free PMC article.
-
Hypoxic pulmonary vasoconstriction.Physiol Rev. 2012 Jan;92(1):367-520. doi: 10.1152/physrev.00041.2010. Physiol Rev. 2012. PMID: 22298659 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources